| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M107440200 |
| P698 | PubMed publication ID | 11726658 |
| P50 | author | Laura Calabresi | Q42755348 |
| Monica Gomaraschi | Q46129915 | ||
| Guido Franceschini | Q57739926 | ||
| P2093 | author name string | Richard W James | |
| Sara Deakin | |||
| Ilia Leviev | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4301-4308 | |
| P577 | publication date | 2001-11-28 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism | |
| P478 | volume | 277 |
| Q39748960 | A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activity |
| Q34138923 | A retained secretory signal peptide mediates high density lipoprotein (HDL) assembly and function of haptoglobin-related protein |
| Q33942724 | A review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect |
| Q33826649 | Alzheimer's Disease and Paraoxonase 1 (PON1) Gene Polymorphisms. |
| Q38062539 | Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. |
| Q40127827 | Application of mass spectrometry to elucidate the pathophysiology of Encephalitozoon cuniculi infection in rabbits. |
| Q88057351 | Association between PON1 rs662 polymorphism and coronary artery disease |
| Q36984390 | Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity |
| Q37086531 | Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice |
| Q33878870 | Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment |
| Q34347361 | Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism |
| Q92533861 | Effects of aerobic training on serum paraoxonase activity and its relationship with PON1-192 phenotypes in women |
| Q35048017 | Effects on transcriptional regulation and lipid droplet characteristics in the liver of female juvenile pigs after early postnatal feed restriction and refeeding are dependent on birth weight. |
| Q34560006 | Enzymatic assessment of cholesterol on electrophoresis gels for estimating HDL size distribution and plasma concentrations of HDL subclasses. |
| Q33976196 | Estradiol enhances cell-associated paraoxonase 1 (PON1) activity in vitro without altering PON1 expression |
| Q39178456 | Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities |
| Q33911488 | Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice |
| Q89939330 | Frontocingulate Dysfunction Is Associated with Depression and Decreased Serum PON1 in Methamphetamine-Dependent Patients |
| Q45341782 | HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress |
| Q28386131 | Human PON1, a biomarker of risk of disease and exposure |
| Q28395898 | Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles |
| Q30580304 | Humidity sensation requires both mechanosensory and thermosensory pathways in Caenorhabditis elegans |
| Q47937635 | Hyperuricemia is Associated with Increased Apo AI Fractional Catabolic Rates and Dysfunctional HDL in New Zealand Rabbits. |
| Q37408897 | IgG-paraoxonase-1 fusion protein for targeted drug delivery across the human blood-brain barrier |
| Q30891417 | In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes |
| Q47332165 | Increased HDL Size and Enhanced Apo A-I Catabolic Rates Are Associated With Doxorubicin-Induced Proteinuria in New Zealand White Rabbits. |
| Q33585638 | Integrated bioprocessing for the pH-dependent production of 4-valerolactone from levulinate in Pseudomonas putida KT2440. |
| Q36564408 | Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability |
| Q28566625 | Modulation of paraoxonase 1 and 3 expression after moderate exercise training in the rat |
| Q41983614 | Novel study on N-nitrosamines as risk factors of cardiovascular diseases |
| Q26824686 | PON1 and Mediterranean Diet |
| Q24602455 | Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity |
| Q35844085 | Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved |
| Q33590383 | Paraoxonase 2 protein is spatially expressed in the human placenta and selectively reduced in labour |
| Q35062406 | Paraoxonase and coronary heart disease |
| Q34269191 | Paraoxonase gene polymorphisms, oxidative stress, and diseases |
| Q51316398 | Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome. |
| Q38806888 | Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells. |
| Q92731226 | Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders |
| Q92315896 | Paraoxonases (PON) 1, 2, and 3 Polymorphisms and PON-1 Activities in Patients with Sickle Cell Disease |
| Q45789658 | Paraoxonases-1, -2 and -3: What are their functions? |
| Q48101614 | Paraoxonases: metabolic role and pharmacological projection. |
| Q37463147 | Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease |
| Q54987133 | Plasma proteins associated with circulating carotenoids in Nepalese school-aged children. |
| Q35098983 | Pleiotropic effects of thyroid hormones: learning from hypothyroidism |
| Q36530464 | Protective Role of Dietary Curcumin in the Prevention of the Oxidative Stress Induced by Chronic Alcohol with respect to Hepatic Injury and Antiatherogenic Markers |
| Q37291848 | Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners? |
| Q35882841 | Regulation of hepatic paraoxonase-1 expression |
| Q54911548 | Resveratrol fails to provide prophylactic protection in a rat model of organophosphate poisoning. |
| Q36735715 | Role of genetic changes in the progression of cardiovascular diseases |
| Q44711817 | Separation and quantitative recovery of mouse serum arylesterase and carboxylesterase activity |
| Q44300028 | Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response |
| Q51772181 | The Scavenger Receptor Class B, Type I Is a Primary Determinant of Paraoxonase-1 Association With High-Density Lipoproteins |
| Q47108138 | The genetic association between PON1 polymorphisms and osteonecrosis of femoral head: A case-control study |
| Q26824356 | The human paraoxonase gene cluster as a target in the treatment of atherosclerosis |
| Q45407290 | The role of cholesterol-enriched diet and paraoxonase 1 inhibition in atherosclerosis progression |
| Q48422098 | Time-dependent modulation of rat serum paraoxonase 1 activity by fasting |
Search more.